drugset / Trial / NCT04172961

Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days

NCT04172961

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will be a randomized, double-blind prospective in 3 clinical sites to compare the efficacy of two currently approved topical ophthalmic drops in the clearing central corneal staining in 90 days prior to elective cataract or LASIK surgery.

Timeline

Start
2020-02-01
Primary completion
2022-12-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.09 % Topical
Comparator Lifitegrast Unknown 5 % Topical

Indications